Moody's Corporation · MCO · FY2026 Q2 · Calendar Q3 2026
Moody's Q2: Revenue Up 15%, EPS Beat of 10%, Guidance Raised as AI Data-Center Financing Surges
Moody's accelerated from 8% revenue growth in Q1 to 15% in Q2, with adjusted EPS of $4.68 beating consensus by roughly 10%. The beat was driven by Moody's Investors Service, where transaction revenue surged 34% on $2 trillion in rated issuance — primarily AI data-center financing and private credit. Moody's Analytics grew ARR to $3.7 billion at approximately 9% year-over-year. Management responded by raising the full-year EPS midpoint to $16.75 and upgrading the issuance outlook to mid-single-digit growth. New strategic milestones included on-chain ratings on Solana, a re-entry into insurance-linked securities via a EUR 100 million flood catbond, and expanded AI integrations with Amazon and Microsoft. Despite the solid quarter, the stock reaction was muted — the abnormal move was essentially flat at -0.10% with subsequent drift of -1.12% — which may reflect the stock's pre-earnings…
Company context
Snapshot as of publicationMoody's Corporation operates as a global leader in risk assessment, divided into two main segments: Moody's Investors Service and Moody's Analytics. Moody's Investors Service is dedicated to issuing credit ratings and providing detailed assessments for a diverse range of debt obligations and the entities that issue them. This encompasses corporate, financial institution, governmental, and structured finance securities across approximately 140 nations. These ratings are made publicly available through press releases, digital media, and real-time financial information systems.…
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Jul 23, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 23, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 20, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 10, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 7, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 7, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Apr 28, 2026 |
| UBS | Neutral | Neutral | Maintain | Feb 19, 2026 |
| Stifel | Buy | Buy | Maintain | Feb 19, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Feb 19, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 9, 2026 |
| Daiwa Capital | Outperform | Neutral | Upgrade | Jan 13, 2026 |
| Raymond James | Market Perform | Underperform | Upgrade | Oct 17, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 9, 2025 |
| Deutsche Bank | Buy | Hold | Upgrade | Oct 1, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 24, 2025 |
| B of A Securities | Buy | Buy | Maintain | Jul 16, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 26, 2023 |
| Argus Research | Buy | Buy | Maintain | Nov 2, 2022 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Jun 8, 2022 |
| Stifel Nicolaus | Hold | Hold | Maintain | Feb 13, 2020 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Feb 13, 2020 |
| PiperJaffray | Neutral | Neutral | Maintain | Apr 5, 2019 |
| Piper Sandler | Neutral | Neutral | Maintain | Apr 5, 2019 |
| Nomura | Buy | Buy | Maintain | Jul 9, 2018 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| FBR Capital | Market Perform | Market Perform | Maintain | Feb 8, 2016 |
| Janney Capital | Neutral | Neutral | Maintain | Mar 28, 2014 |
| Benchmark | Hold | Hold | Maintain | Oct 28, 2013 |
| Lazard | Buy | Buy | Maintain | Sep 25, 2013 |
| William Blair | Outperform | Outperform | Maintain | Sep 9, 2013 |
| BTIG Research | Sell | Sell | Maintain | Jul 11, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $484.2. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Sean Kennedy | $530 | $488.89 | +9.5% | Jul 27, 2026 |
| UBS | Alex Kramm | $505 | $473.95 | +4.3% | Jul 23, 2026 |
| Robert W. Baird | Analyst unavailable | $572 | $477.81 | +18.1% | Jul 23, 2026 |
| Wells Fargo | Analyst unavailable | $597 | $489.79 | +23.3% | Jul 23, 2026 |
| Morgan Stanley | Analyst unavailable | $512 | $489.79 | +5.7% | Jul 22, 2026 |
| Barclays | Analyst unavailable | $575 | $487.02 | +18.8% | Jul 10, 2026 |
| Morgan Stanley | Analyst unavailable | $496 | $502.26 | +2.4% | Jul 7, 2026 |
| BMO Capital | Analyst unavailable | $515 | $498.78 | +6.4% | Jul 7, 2026 |
| Redburn Partners | Charles Bendit | $500 | $456.22 | +3.3% | Jun 18, 2026 |
| Mizuho Securities | Analyst unavailable | $521 | $460.74 | +7.6% | Apr 28, 2026 |
| Wolfe Research | Scott Wurtzel | $535 | $451.74 | +10.5% | Apr 23, 2026 |
| BMO Capital | Analyst unavailable | $489 | $454.18 | +1.0% | Apr 23, 2026 |
| Wells Fargo | Analyst unavailable | $590 | $466.88 | +21.9% | Apr 23, 2026 |
| National Bank | Analyst unavailable | $565 | $466.88 | +16.7% | Apr 22, 2026 |
| Mizuho Securities | Analyst unavailable | $524 | $437.11 | +8.2% | Feb 24, 2026 |
| Barclays | Analyst unavailable | $550 | $447.82 | +13.6% | Feb 23, 2026 |
| UBS | Analyst unavailable | $490 | $442.78 | +1.2% | Feb 19, 2026 |
| Evercore ISI | David Motemaden | $610 | $448.74 | +26.0% | Feb 19, 2026 |
| BMO Capital | Analyst unavailable | $480 | $450.76 | -0.9% | Feb 19, 2026 |
| Stifel Nicolaus | Analyst unavailable | $540 | $450.76 | +11.5% | Feb 19, 2026 |
| Goldman Sachs | Analyst unavailable | $531 | $450.76 | +9.7% | Feb 18, 2026 |
| Goldman Sachs | Analyst unavailable | $532 | $452.49 | +9.9% | Feb 9, 2026 |
| Morgan Stanley | Toni Kaplan | $526 | $535.12 | +8.6% | Jan 13, 2026 |
| Daiwa | Kazuya Nishimura | $590 | $535.12 | +21.9% | Jan 13, 2026 |
| Evercore ISI | Analyst unavailable | $620 | $533.78 | +28.0% | Jan 8, 2026 |
| Stifel Nicolaus | Shlomo Rosenbaum | $574 | $498.98 | +18.5% | Jan 5, 2026 |
| Goldman Sachs | Analyst unavailable | $570 | $487.37 | +17.7% | Dec 16, 2025 |
| Mizuho Securities | Sean Kennedy | $550 | $494.44 | +13.6% | Oct 28, 2025 |
| BMO Capital | Analyst unavailable | $507 | $471.75 | +4.7% | Oct 23, 2025 |
| Stifel Nicolaus | Analyst unavailable | $471 | $472.79 | -2.7% | Oct 23, 2025 |
| Wells Fargo | Jason Haas | $620 | $472.79 | +28.0% | Oct 23, 2025 |
| BMO Capital | Jeffrey Silber | $521 | $478.51 | +7.6% | Oct 16, 2025 |
| Mizuho Securities | Sean Kennedy | $539 | $478.51 | +11.3% | Oct 16, 2025 |
| Morgan Stanley | Analyst unavailable | $520 | $490.09 | +7.4% | Oct 9, 2025 |
| Seaport Global | Analyst unavailable | $528 | $476.48 | +9.0% | Oct 1, 2025 |
| Deutsche Bank | Faiza Alwy | $528 | $476.48 | +9.0% | Oct 1, 2025 |
| BMO Capital | Jeffrey Silber | $456 | $430.77 | -5.8% | Apr 23, 2025 |
| Barclays | Analyst unavailable | $520 | $402.43 | +7.4% | Apr 4, 2025 |
| Oppenheimer | Owen Lau | $545 | $476.27 | +12.6% | Jan 3, 2025 |
| Oppenheimer | Owen Lau | $543 | $467.73 | +12.1% | Oct 23, 2024 |
| Robert W. Baird | Jeffrey Meuler | $512 | $467.73 | +5.7% | Oct 23, 2024 |
| BMO Capital | Jeffrey Silber | $464 | $479.44 | -4.2% | Oct 15, 2024 |
| Oppenheimer | Owen Lau | $536 | $470.19 | +10.7% | Oct 3, 2024 |
| Evercore ISI | David Motemeden | $521 | $471.4 | +7.6% | Oct 1, 2024 |
| UBS | Alex Kramm | $470 | $451.89 | -2.9% | Jul 24, 2024 |
| Robert W. Baird | Jeffrey Meuler | $490 | $451.89 | +1.2% | Jul 24, 2024 |
| UBS | Alex Kramm | $455 | $435.58 | -6.0% | Jul 9, 2024 |
| Oppenheimer | Owen Lau | $454 | $420.93 | -6.2% | Jul 1, 2024 |
| RBC Capital | Ashish Sabadra | $450 | $412.02 | -7.1% | May 16, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $374 | $387.7 | -22.8% | May 7, 2024 |
| Oppenheimer | Owen Lau | $424 | $393.89 | -12.4% | Apr 2, 2024 |
| Barclays | Manav Patnaik | $450 | $393.89 | -7.1% | Apr 2, 2024 |
| Goldman Sachs | George Tong | $412 | $393.03 | -14.9% | Apr 1, 2024 |
| Oppenheimer | Owen Lau | $362 | $341.49 | -25.2% | Jul 7, 2023 |
| Oppenheimer | Analyst unavailable | $342 | $319.98 | -29.4% | Feb 1, 2023 |
| Barclays | Analyst unavailable | $300 | $322.75 | -38.0% | Feb 1, 2023 |
| Morgan Stanley | Analyst unavailable | $293 | $284.96 | -39.5% | Jan 4, 2023 |
| Morgan Stanley | Analyst unavailable | $294 | $293.16 | -39.3% | Dec 6, 2022 |
| Barclays | Analyst unavailable | $275 | $306.08 | -43.2% | Dec 2, 2022 |
| Goldman Sachs | Analyst unavailable | $295 | $297.54 | -39.1% | Nov 23, 2022 |
| Oppenheimer | Analyst unavailable | $310 | $294.36 | -36.0% | Nov 23, 2022 |
| Morgan Stanley | Analyst unavailable | $271 | $289.37 | -44.0% | Nov 17, 2022 |
| Morgan Stanley | Analyst unavailable | $281 | $250.3 | -42.0% | Oct 3, 2022 |
| Goldman Sachs | Analyst unavailable | $263 | $245 | -45.7% | Oct 3, 2022 |
| Morgan Stanley | Analyst unavailable | $288 | $251.4 | -40.5% | Sep 27, 2022 |
| Oppenheimer | Analyst unavailable | $348 | $313.94 | -28.1% | Aug 19, 2022 |
| BMO Capital | Analyst unavailable | $352 | $324.6 | -27.3% | Aug 15, 2022 |
| Morgan Stanley | Analyst unavailable | $283 | $286.17 | -41.6% | Jul 27, 2022 |
| Raymond James | Analyst unavailable | $321 | $286.57 | -33.7% | Jul 27, 2022 |
| Raymond James | Analyst unavailable | $327 | $280.95 | -32.5% | Jul 12, 2022 |
| Morgan Stanley | Analyst unavailable | $298 | $282.99 | -38.5% | Jul 7, 2022 |
| RBC Capital | Analyst unavailable | $329 | $284.53 | -32.1% | Jun 7, 2022 |
| UBS | Analyst unavailable | $288 | $285.28 | -40.5% | Jun 6, 2022 |
| Deutsche Bank | Analyst unavailable | $324 | $289.49 | -33.1% | Jun 2, 2022 |
| BMO Capital | Analyst unavailable | $309 | $281.11 | -36.2% | Jun 2, 2022 |
| Morgan Stanley | Analyst unavailable | $305 | $282.38 | -37.0% | Jun 2, 2022 |
| Deutsche Bank | Analyst unavailable | $372 | $304.6 | -23.2% | May 3, 2022 |
| Morgan Stanley | Analyst unavailable | $318 | $302.09 | -34.3% | May 3, 2022 |
| Barclays | Analyst unavailable | $350 | $301.13 | -27.7% | May 3, 2022 |
| Credit Suisse | Analyst unavailable | $350 | $303.06 | -27.7% | May 3, 2022 |
| RBC Capital | Analyst unavailable | $344 | $301.13 | -29.0% | May 3, 2022 |
| Raymond James | Analyst unavailable | $364 | $301.13 | -24.8% | May 3, 2022 |
| Morgan Stanley | Toni Kaplan | $318 | $309.42 | -34.3% | May 3, 2022 |
| Robert W. Baird | Jeffrey Meuler | $342 | $301.13 | -29.4% | May 2, 2022 |
| BMO Capital | Jeffrey Silber | $375 | $322.42 | -22.6% | Apr 23, 2022 |
| Deutsche Bank | Faiza Alwy | $408 | $340.33 | -15.7% | Apr 3, 2022 |
| BMO Capital | Jeffrey Silber | $365 | $304.47 | -24.6% | Mar 12, 2022 |
| Robert W. Baird | Jeffrey Meuler | $363 | $314 | -25.0% | Mar 10, 2022 |
| RBC Capital | Ashish Sabadra | $403 | $314 | -16.8% | Mar 10, 2022 |
| Stifel Nicolaus | Shlomo Rosenbaum | $385 | $325.84 | -20.5% | Mar 4, 2022 |
| BMO Capital | Jeffrey Silber | $402 | $323.58 | -17.0% | Feb 21, 2022 |
| Goldman Sachs | George Tong | $396 | $376.52 | -18.2% | Jul 28, 2021 |
| Argus Research | John Eade | $375 | $326.25 | -22.6% | May 5, 2021 |
Track every rating change on MCO the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session closeFollow MCO with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Revenue growth accelerated from 8% in Q1 to 15% in Q2, with adjusted EPS rising from $4.33 (up 13% YoY in Q1) to $4.68 (up 31% YoY in Q2). Guidance sentiment shifted from maintained to raised: management increased the full-year EPS midpoint to $16.75 and upgraded the issuance outlook to mid-single-digit growth. Moody's Investors Service transaction revenue jumped 34%, the primary growth engine this quarter versus the more balanced 8% growth across both segments in Q1. New product milestones not present in Q1 include on-chain ratings on Solana via AlphaLedger, re-entry into the insurance-linked securities market with a EUR 100 million flood catbond, and integration of Moody's data into Amazon QuickSight. The Q1 leadership transition (Christina Kosmowski becoming MA CEO) and Regulatory Solutions divestiture appear to have settled, with Q2 focused on execution and AI-driven growth.
Guidance delta
Management shifted from maintaining guidance in Q1 to actively raising it in Q2. The full-year adjusted EPS midpoint was raised to $16.75, and the issuance outlook was upgraded to mid-single-digit growth. Full-year high-single-digit ARR growth guidance for Moody's Analytics was maintained. No change to the $2.5 billion share repurchase guidance announced in Q1 was mentioned.
Key takeaways
- Q2 revenue grew 15% to $2.19B with adjusted EPS of $4.68, beating consensus EPS of $4.26 by approximately 10% and revenue of $2.09B by approximately 5%.
- Moody's Investors Service transaction revenue surged 34%, supported by $2 trillion in rated issuance volume driven primarily by AI data-center financing and private credit.
- Moody's Analytics ARR reached $3.7 billion with approximately 9% year-over-year growth; full-year high-single-digit ARR growth guidance maintained.
- Full-year adjusted EPS midpoint raised to $16.75 and issuance outlook upgraded to mid-single-digit growth.
- New strategic milestones: on-chain ratings on Solana via AlphaLedger, re-entry into insurance-linked securities with a EUR 100 million flood catbond, and Moody's data integrated into Amazon QuickSight plus an AI skill for Microsoft 365 Copilot.
Management priorities
- Scale AI-driven Connected Intelligence across Amazon, Microsoft, and AWS ecosystems
- Migrate remaining on-premises customers to the cloud-based Intelligent Risk Platform
- Expand token rating coverage and integration with additional blockchains
- Grow insurance-linked securities and catastrophe underwriting capabilities
- Strengthen data layer and agentic intelligence to simplify go-to-market and pricing
Related earnings events
Financial ServicesSources
- Earnings call transcript and parsed analysis · 2026-07-22T17:02:17.865672+00:00
- FN2 earnings calendar · 2026-07-29T01:23:15.868211+00:00
- Polygon adjusted daily market bars · 2026-07-29T07:34:05.274430+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-29T07:34:05.271338+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.